Menu
Search
|

Menu

Close
X

Cellular Biomedicine Group Inc CBMG.OQ (NASDAQ Stock Exchange Global Market)

16.95 USD
-0.10 (-0.59%)
As of Feb 23
chart
Previous Close 17.05
Open 17.20
Volume 2,168
3m Avg Volume 12,812
Today’s High 17.35
Today’s Low 16.80
52 Week High 22.75
52 Week Low 5.15
Shares Outstanding (mil) 14.01
Market Capitalization (mil) 237.47
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
1
FY15
3
EPS (USD)
FY17
-1.298
FY16
-2.063
FY15
-1.694
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.62
Price to Sales (TTM)
vs sector
728.54
8.35
Price to Book (MRQ)
vs sector
4.80
5.22
Price to Cash Flow (TTM)
vs sector
--
25.88
Total Debt to Equity (MRQ)
vs sector
0.00
15.84
LT Debt to Equity (MRQ)
vs sector
0.00
12.39
Return on Investment (TTM)
vs sector
-40.98
13.63
Return on Equity (TTM)
vs sector
-40.99
15.39

EXECUTIVE LEADERSHIP

Terry Belmont
Chairman of the Board, Since 2016
Salary: --
Bonus: --
Bizuo Liu
Chief Executive Officer, Interim Chief Financial Officer, Secretary, Since 2016
Salary: $155,491.00
Bonus: --
Yihong Yao
Chief Scientific Officer, Since 2015
Salary: --
Bonus: --
Xia Meng
Head of Early Diagnosis & Intervention, Since 2018
Salary: --
Bonus: --
Richard Wang
Chief Operation Officer, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

19925 Stevens Creek Blvd Ste 100
CUPERTINO   CA   95014-2384

Phone: +1408.9737884

Cellular Biomedicine Group Inc. is a United States-based company which is engaged in the development of cell therapy technologies. The Company develops proprietary cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from the good manufacturing practices (GMP) laboratory.

SPONSORED STORIES